Robin Lachapelle
Chief Operating Officer, ArriVent BioPharma, Inc.
Companies
- ArriVent BioPharma, Inc.Chief operating officer Jan 25, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ArriVent BioPharma, Inc. AVBP530,213 shares2$9.4M at $17.70Jul 15, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 11, 2025Exercised options 6,503 shares at $2.28 of ArriVent BioPharma, Inc.2
- Jul 11, 2025Exercised options 2,600 shares at $2.28 of ArriVent BioPharma, Inc.2
- Jul 11, 2025Exercised options 2,050 shares at $2.28 of ArriVent BioPharma, Inc.2
- Sep 19, 2024Exercised options 12,364 shares at $3.65 of ArriVent BioPharma, Inc.3
- Sep 19, 2024Exercised options 2,471 shares at $2.28 of ArriVent BioPharma, Inc.3
- Sep 19, 2024Exercised options 7,164 shares at $2.28 of ArriVent BioPharma, Inc.3
- Sep 19, 2024Exercised options 2,867 shares at $2.28 of ArriVent BioPharma, Inc.3
- Sep 19, 2024Exercised options 2,700 shares at $6.24 of ArriVent BioPharma, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Sep 23, 2024